10-Q: Sentient Brands Holdings Inc. Reports First Quarter 2024 Results with Increased Net Loss
Quarterly Report
Sentient Brands Holdings Inc. reported a net loss of $416,754 for the first quarter of 2024, significantly higher than the $75,845 loss in the same period of 2023, primarily due to increased legal and professional fees.
Summary
- Sentient Brands Holdings Inc. reported its financial results for the first quarter of 2024, showing a net loss of $416,754, which is substantially greater than the $75,845 loss reported in the first quarter of 2023.
- The company's operating expenses increased significantly, reaching $352,769 in Q1 2024 compared to $35,359 in Q1 2023, largely due to a substantial rise in legal and professional fees.
- The company's revenue was minimal at $150 in Q1 2023 and $0 in Q1 2024.
- The company's cash balance increased to $67,693 as of March 31, 2024, compared to $1,299 at the end of 2023, due to financing activities.
- The company's total current liabilities were $2,348,370 as of March 31, 2024, resulting in a working capital deficit of $2,115,337.
- The company issued 2,000,000 shares of common stock for services and additional shares for cash during the quarter.
- The company has identified material weaknesses in its internal controls over financial reporting.
Sentiment
Score: 3
Explanation: The document indicates significant financial losses, material weaknesses in internal controls, and a going concern risk, which are all negative indicators for investors. While there are some positives, such as increased cash balance, the overall tone is concerning.
Positives
- The company's cash balance increased significantly to $67,693 due to financing activities.
- The company is actively pursuing growth strategies, including partnerships and operational excellence.
Negatives
- The company experienced a substantial increase in net loss, reaching $416,754 in Q1 2024.
- Operating expenses increased dramatically, primarily due to a significant rise in legal and professional fees.
- The company has a significant working capital deficit of $2,115,337.
- The company has identified material weaknesses in its internal controls over financial reporting.
Risks
- The company's ability to continue as a going concern is dependent on raising additional capital and achieving profitable operations.
- The company faces intense competition in the hemp-derived CBD market.
- The company's internal controls over financial reporting are not effective, which could lead to material misstatements.
- The company has a significant working capital deficit, which could impact its ability to operate effectively.
Future Outlook
The company plans to grow by leveraging its network, increasing brand awareness, and investing in social media marketing. They also intend to launch new products and explore M&A opportunities. The company's ability to continue as a going concern is dependent on raising additional capital and achieving profitable operations.
Management Comments
- The company's goal is to create customer experiences that have sustainable resonance with consumers and consistently implement strategies that result in long-term profit growth.
- The company believes it has assembled a highly accomplished team of branding and marketing professionals.
- Management believes that it currently has sufficient human capital to operate its business successfully.
Industry Context
The company operates in the competitive hemp-derived CBD market, which is expected to grow substantially. The company is targeting the luxury and premium market segments with its Oeuvre product line, aiming to capture a share of the growing market for CBD-based wellness and beauty products.
Comparison to Industry Standards
- The company's revenue is significantly lower than many of its competitors in the CBD market, as most industry participants generate less than $2 million in annual revenue.
- The company's net loss is substantial compared to some of its publicly listed competitors, such as Charlottes Web and CV Sciences, which have more established revenue streams.
- The company's focus on the luxury segment with its Oeuvre brand is a differentiator, but it also faces competition from other high-end CBD brands like BeBoe and Lord Jones.
- The company's reliance on third-party suppliers is common in the industry, but it also introduces supply chain risks.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Controls | The company identified material weaknesses in its internal controls over financial reporting, including lack of written documentation, insufficient segregation of duties, and ineffective controls over the control environment. | 2024-03-31 | The material weaknesses could lead to material misstatements in the financial statements. |
Legal Proceedings
- The company is currently involved in a wage dispute with a former contractor dating back to the third quarter of 2020. The company disputes the claim in its entirety but has maintained an accrual of $ 54,000 related to the dispute.
Stakeholder Impact
- Shareholders are impacted by the significant net loss and the going concern risk.
- Employees may be impacted by the company's financial instability and potential restructuring.
- Customers may be impacted by potential changes in product availability or quality due to financial constraints.
- Creditors may be impacted by the company's ability to repay its debts.
Next Steps
- The company plans to raise additional capital through the sale of equity or debt instruments.
- The company intends to implement its business plan and generate significant revenues.
- The company plans to engage a third-party firm to assist in remedying the material weakness in internal controls.
- The company intends to hire additional employees to segregate duties and establish effective internal controls.
Key Dates
| Date | Description |
|---|---|
| 2018-05-01 | Date of advances from Pure Energy 714 LLC. |
| 2019-03-14 | Specific terms reached on some advances from Pure Energy 714 LLC. |
| 2019-12-25 | Employment Agreement with George Furlan. |
| 2020-01-07 | Executive Consulting Agreement with James Mansour. |
| 2020-01-02 | Specific terms reached on remaining advances from Pure Energy 714 LLC. |
| 2020-12-02 | Promissory note issued to an accredited investor. |
| 2020-12-03 | Convertible debenture issued to an accredited investor. |
| 2021-01-29 | Company merged with its Nevada subsidiary. |
| 2021-03-02 | Forward stock split and name change effective date. |
| 2021-04-27 | Securities Purchase Agreement with an accredited investor. |
| 2021-11-18 | Securities Purchase Agreement with an accredited investor. |
| 2022-08-19 | Extension agreement for April 2021 Note. |
| 2023-01-05 | Issuance of restricted shares to George Furlan, an independent contractor, and Dante Jones. |
| 2023-08-09 | Agreement to issue restricted shares to a qualified investor. |
| 2023-09-28 | Agreement to issue restricted shares to a qualified investor. |
| 2023-12-03 | Noteholder exercised warrants. |
| 2023-12-27 | Noteholder exercised warrants. |
| 2024-01-23 | Sale of common stock to an investor. |
| 2024-02-15 | Issuance of common stock to an investor. |
| 2024-02-22 | Issuance of common stock to multiple investors. |
| 2024-03-14 | Issuance of common stock to a consultant. |
| 2024-03-28 | Settlement and Release Agreement with a vendor. |
| 2024-04-09 | Issuance of common stock to a vendor. |
| 2024-04-10 | Issuance of common stock for consulting services. |
| 2024-04-30 | Issuance of common stock to the CEO in lieu of cash payment. |
Keywords
CBD, luxury skincare, financial results, net loss, operating expenses, internal controls, going concern, capital raise, Sentient Brands, Oeuvre
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.